AllianceBernstein’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-75,283
| Closed | -$708K | – | 3244 |
|
|
2020
Q3 | $708K | Sell |
75,283
-5,990
| -7% | -$56.9K | ﹤0.01% | 2338 |
|
|
2020
Q2 | $622K | Buy |
81,273
+6,370
| +9% | +$48.7K | ﹤0.01% | 2468 |
|
|
2020
Q1 | $463K | Buy |
74,903
+50
| +0.1% | +$441 | ﹤0.01% | 2394 |
|
|
2019
Q4 | $911K | Sell |
74,853
-10,400
| -12% | -$114K | ﹤0.01% | 2317 |
|
|
2019
Q3 | $985K | Buy |
85,253
+300
| +0.4% | +$3.16K | ﹤0.01% | 2256 |
|
|
2019
Q2 | $849K | Buy |
84,953
+25,300
| +42% | +$273K | ﹤0.01% | 2386 |
|
|
2019
Q1 | $768K | Hold |
59,653
| – | – | ﹤0.01% | 2361 |
|
|
2018
Q4 | $906K | Hold |
59,653
| – | – | ﹤0.01% | 2238 |
|
|
2018
Q3 | $1.19M | Sell |
59,653
-4,710
| -7% | -$107K | ﹤0.01% | 2244 |
|
|
2018
Q2 | $1.25M | Buy |
64,363
+1,920
| +3% | +$42.5K | ﹤0.01% | 2197 |
|
|
2018
Q1 | $1.26M | Buy |
62,443
+13,890
| +29% | +$235K | ﹤0.01% | 2121 |
|
|
2017
Q4 | $643K | Sell |
48,553
-11,800
| -20% | -$178K | ﹤0.01% | 2462 |
|
|
2017
Q3 | $1.11M | Hold |
60,353
| – | – | ﹤0.01% | 2223 |
|
|
2017
Q2 | $1.11M | Sell |
60,353
-40,770
| -40% | -$808K | ﹤0.01% | 2242 |
|
|
2017
Q1 | $2.28M | Sell |
101,123
-65,080
| -39% | -$1.56M | ﹤0.01% | 1721 |
|
|
2016
Q4 | $5.78M | Sell |
166,203
-12,610
| -7% | -$377K | ﹤0.01% | 1114 |
|
|
2016
Q3 | $4.38M | Buy |
178,813
+114,640
| +179% | +$2.87M | ﹤0.01% | 1186 |
|
|
2016
Q2 | $1.53M | Buy |
64,173
+8,600
| +15% | +$197K | ﹤0.01% | 1935 |
|
|
2016
Q1 | $1.3M | Hold |
55,573
| – | – | ﹤0.01% | 1929 |
|
|
2015
Q4 | $1.68M | Sell |
55,573
-1,090
| -2% | -$35.2K | ﹤0.01% | 1762 |
|
|
2015
Q3 | $2.25M | Buy |
56,663
+3,990
| +8% | +$248K | ﹤0.01% | 1557 |
|
|
2015
Q2 | $3.64M | Buy |
52,673
+8,200
| +18% | +$516K | ﹤0.01% | 1296 |
|
|
2015
Q1 | $2.43M | Hold |
44,473
| – | – | ﹤0.01% | 1586 |
|
|
2014
Q4 | $1.9M | Buy |
44,473
+3,100
| +7% | +$112K | ﹤0.01% | 1786 |
|
|
2014
Q3 | $1.32M | Buy |
41,373
+4,100
| +11% | +$87.4K | ﹤0.01% | 2016 |
|
|
2014
Q2 | $772K | Sell |
37,273
-137
| -0.4% | -$2.53K | ﹤0.01% | 2376 |
|
|
2014
Q1 | $724K | Sell |
37,410
-6,217
| -14% | -$132K | ﹤0.01% | 2313 |
|
|
2013
Q4 | $1.06M | Hold |
43,627
| – | – | ﹤0.01% | 2122 |
|
|
2013
Q3 | $937K | Sell |
43,627
-626
| -1% | -$14.8K | ﹤0.01% | 2158 |
|
|
2013
Q2 | $985K | Buy |
+44,253
| New | +$975K | ﹤0.01% | 2087 |
|
AllianceBernstein's AMAG Position: Q4 2020 in Review
AllianceBernstein sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 75,283 shares — an estimated $708K sold.
AllianceBernstein first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $5.78M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- AllianceBernstein reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- AllianceBernstein sold 75,283 AMAG Pharmaceuticals shares in Q4 2020, an estimated $708K.
- AllianceBernstein first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- AllianceBernstein's AMAG Pharmaceuticals position peaked at $5.78M in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on AllianceBernstein's 13F filing for Q4 2020, filed 8 Feb 2021.